ARCHIVES

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

This article is from The Cancer Letter archive.

Vol. 18 No. 15 | April 10, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

Cancer Research Institute Goes To Wall Street

January 17, 1986

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979

House: NCI Should Coordinate National Cancer Program

August 4, 1995

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014